why choose us

300×250 Ad Slot

Research Article: Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

Date Published: 2024-03-27

Abstract:
Introduction: Immune checkpoint inhibitors have made a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). However, clinical response varies widely and robust predictive biomarkers for patient stratification are lacking. Here, we characterize early on-treatment proteomic changes in blood plasma to gain a better understanding of treatment response and resistance.

No summary available.

300×250 Ad Slot